Publications by authors named "J A Atwell"
Article Synopsis
- A study reviewed RSV (respiratory syncytial virus) data from 149 countries across WHO regions to assess pediatric burdens from 2012 to 2022.
- A gap analysis revealed wide variations in hospitalization rates, mortality, and case definitions, with infants under 6 months at higher risk and needing longer hospital stays.
- Findings indicate significant regional differences in RSV impact and highlight the need for standardized data to better understand and address this health issue globally.
Article Synopsis
- The study focused on analyzing RSV infection risks in children under 24 months in Valladolid from 2010 to 2022, comparing these risks with those of influenza and COVID-19.
- It involved a retrospective cohort study of 1,507 RSV cases, revealing that hospitalized RSV patients were generally younger and had lower comorbidity rates than those with influenza or COVID-19.
- Key findings indicated that factors like prematurity, maternal smoking, and coinfection increased the risk of severe RSV outcomes, while breastfeeding and complete vaccination were protective against hospitalization and severity.
Introduction: Respiratory syncytial virus (RSV) causes a substantial disease burden among infants. In older children and adults, incidence is underestimated due to nonspecific symptoms and limited standard-of-care testing. We aimed to estimate RSV-attributable hospitalizations and deaths in Spain during 2016-2019.
View Article and Find Full Text PDFBackground: Post-COVID conditions encompass a range of long-term symptoms after SARS-CoV-2 infection. The potential clinical and economic burden in the United States is unclear. We evaluated diagnoses, medications, healthcare use, and medical costs before and after acute COVID-19 illness in US patients at high risk of severe COVID-19.
View Article and Find Full Text PDFBackground: The aim of this study was to estimate the impact of mild-to-moderate COVID-19 on health-related quality of life (HRQoL) over time among individuals in the United Kingdom, adding to the evidence base that had focussed on severe COVID-19.
Methods: A bespoke online survey was administered to individuals who self-reported a positive COVID-19 test. An amended version of a validated generic HRQoL instrument (EQ-5D-5L) was used to measure HRQoL retrospectively at different timepoints over the course of an infection: pre-COVID-19, acute COVID-19, and long COVID.